The present invention includes methods for treating a PDGFR伪 mutated proliferative disorder in a subject relapsed/refractory to prior tyrosine kinase inhibitor therapy comprising administering to the subject a therapeutically effective of crenolanib,; ;wherein the subject is relapsed/refractory to prior ...